home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

18.61 -0.49 (-2.57%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Shares of MacroGenics Jumped Thursday ↗

March 09, 2023

The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.

Via The Motley Fool

2 Growth Stocks With Incredible Potential in the Next 5 Years ↗

March 06, 2023

Neither is profitable, but both could be on the verge of massive booms in revenue.

Via The Motley Fool

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Zai Lab's Earnings: A Preview ↗

February 28, 2023

Via Benzinga

What's Going On With Zai Lab Stock ↗

January 04, 2023

Zai Lab Ltd - ADR (NASDAQ: ZLAB) shares are trading higher by 7.04% to $33.01 Wednesday morning.

Via Benzinga

Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday ↗

March 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 02, 2023

Gainers Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million...

Via Benzinga

Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates

March 01, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces Participation in March Investor Conferences

February 28, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

February 22, 2023

From Zai Lab Limited

Via GlobeNewswire

3 More Mid-Cap Biotechs The Street Sees Doubling

February 22, 2023

According to Wall Street research groups, these three mid-cap biotechs have 2x potential. It’s for the investor to decide if the upside justifies the risk.

Via MarketBeat

Zai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA

February 22, 2023

From Zai Lab Limited

Via GlobeNewswire

Mixed Signals On Valentine's Day: How Stocks Are Reacting To January Inflation Data ↗

February 14, 2023

Inflation cooled slightly in January, but saw increases in some areas due to the impact of surging food, energy and shelter prices on consumers, the U.S Labor Department said Tuesday.

Via Benzinga

Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023

February 09, 2023

Company to Host Conference Call and Webcast on March 2, 2023, at 8:00 a.m. ET

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces Participation in February Investor Conferences

January 31, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by China’s NMPA

January 30, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in China’s National Reimbursement Drug List

January 18, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Appoints Michel Vounatsos To Its Board of Directors

January 09, 2023

From Zai Lab Limited

Via GlobeNewswire

Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review ↗

January 06, 2023

The major indexes rallied Friday on the jobs report and services data.

Via Investor's Business Daily

Why Shares of Zai Lab Soared This Week ↗

January 05, 2023

A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.

Via The Motley Fool

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 05, 2023

Via Benzinga

Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients ↗

January 05, 2023

Via Benzinga

This Good News on Cancer Sent 2 Nasdaq Stocks Soaring ↗

January 05, 2023

Biotech investors are optimistic about the prospects for a potential treatment.

Via The Motley Fool

US Stocks Open Lower; Dow Tumbles 300 Points ↗

January 05, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 05, 2023

Via Benzinga

Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

January 05, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development

January 03, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces Participation in January Investor Conferences

December 20, 2022

From Zai Lab Limited

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com